Patient recruitment is one of the most important factors while deciding the potential of the clinical trial industry. The recruitment of patients depends upon the factors like size and availability of patient population. Russia has a vast patient pool as reflected by its huge population as compared to the other Eastern European countries. Russia’s market backed by favorable demographic characteristics also enjoys high level of patient recruitment in the new studies. As per our new research on the sector “ Clinical Trials Market in Russia”, the number of clinical trial studies in Russia is anticipated to grow at a CAGR of around 8% during 2010-2012.
We have found that the standards of clinical studies in Russia have improved a lot in last few years and GCP standards are being followed in almost all the studies being conducted in the country. As a result of this, all major regulatory organizations worldwide have started accepting the result of clinical studies conducted in Russia. This factor has boosted the growth of Russian clinical trial industry as numbers of clinical trials have increased at a robust rate. In this regard, our report provides analysis on various market factors that are driving the overall industry growth.
The report also provides a complete analysis on the cost factor involved in the clinical studies. The report also compares the cost of conducting clinical trials in Russia with various other developed markets.
“ Clinical Trials Market in Russia” gives comprehensive information of the clinical trials market in Russia. The report includes thorough evaluation of the current trends and various industry restraints to project an actual and non-biased picture of the industry. Besides, it covers information of various major players present in the market. The report will prove a useful investment guide for investors looking for investment opportunities in the market.
For more information visit: http://www.rncos.com/Report/IM189.htm |
